Zhi Yang

Zhi Yang

CEO

Fasikl

Year

Description

Technology that can read minds to give amputees better control of prosthetic limbs sounds like the stuff of science fiction, but Zhi Yang says it’s steadily becoming a reality at Fasikl. The company has developed “brain-machine interface” technology designed to give amputees more intuitive control over prosthetics. The same technology can also be used to help alleviate post-amputation pain, which can persist for years in some patients. A year ago, Fasikl, a University of Minnesota spinoff, earned a pair of “breakthrough device designations” from the FDA for the technology. “We think this can help many people,” Yang says.

Return to TCB 100 for 2024